Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine 30 mg in Fibromyalgia
NCT00965081Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in fibromyalgia (FM) comparing Duloxetine with Placebo (2 arms). Primary endpoint: Brief Pain Inventory 24-Hour Average Pain Item at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00965081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965081.